children

Speech disorders impacting children have debilitating impacts on educational, social and later employment outcomes. There are limited therapeutic…

Redenlab, a leading provider of innovative solutions in the field of pediatric and neurodevelopment communication, proudly announces that…

Dentatorubral-pallidoluysian atrophy (DRPLA) is a rare progressive brain disorder that can impact children and adults. In children, DRPLA…

L16HTHOUSE is a research trial testing an experimental medication for treating speech, motor, learning, and other developmental delays…

Redenlab Inc. are pleased to announce securing clinical trial in Cyclic Vomiting Syndrome with a Top 10 pharma…